Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386776723> ?p ?o ?g. }
- W4386776723 endingPage "e19893" @default.
- W4386776723 startingPage "e19893" @default.
- W4386776723 abstract "Cancer stem cells (CSCs) are the most challenging issue in cancer treatment, because of their high resistance mechanisms, that can cause tumor recurrence after common cancer treatments such as drug and radiation based therapies, and the insufficient efficiency of common treatments in CSCs removal and the recurrence of tumors after these treatments, it is essential to consider other methods, including non-ionizing treatments likes light-based treatments and magnetic hyperthermia (MHT).After synthesis, characterization and investigation, the toxicity of novel on A375 and MAD-MB-231 cell lines, magnetic hyperthermia and light-based treatments were applied. MTT assay and flow cytometry was employed to determine cell survival. the influence of combination therapy on CD44 + CD24-and CD133 + CD44+ cell population, Comparison and evaluation of combination treatments was done respectively using Combination Indices (CIs).The final nanoparticle has a high efficiency in producing hydroxyl radicals and generating heat in MHT. According to CIs, we can conclude that combined using of light-based treatment and MHT in the presence of final synthesized nanoparticle have synergistic effect and a high ability to reduce the population of stem cells in both cell lines compared to single treatments.In this study a novel multi-functional nanoplatform acted well in dual and triple combined treatments, and showed a good performance in the eradication of CSCs, in A375 and MAD-MB-231 cell lines." @default.
- W4386776723 created "2023-09-16" @default.
- W4386776723 creator A5006780462 @default.
- W4386776723 creator A5019815322 @default.
- W4386776723 creator A5039801518 @default.
- W4386776723 creator A5051131961 @default.
- W4386776723 creator A5084551363 @default.
- W4386776723 creator A5089813224 @default.
- W4386776723 date "2023-10-01" @default.
- W4386776723 modified "2023-10-11" @default.
- W4386776723 title "Cobalt ferrite nanoparticle for the elimination of CD133+CD44+ and CD44+CD24−, in breast and skin cancer stem cells, using non-ionizing treatments" @default.
- W4386776723 cites W1750911959 @default.
- W4386776723 cites W1965097716 @default.
- W4386776723 cites W1976649025 @default.
- W4386776723 cites W1979924714 @default.
- W4386776723 cites W1981170008 @default.
- W4386776723 cites W1994139105 @default.
- W4386776723 cites W1997847812 @default.
- W4386776723 cites W2007260110 @default.
- W4386776723 cites W2024310259 @default.
- W4386776723 cites W2025531782 @default.
- W4386776723 cites W2036954929 @default.
- W4386776723 cites W2037611887 @default.
- W4386776723 cites W2047432417 @default.
- W4386776723 cites W2050467075 @default.
- W4386776723 cites W2053590736 @default.
- W4386776723 cites W2053790124 @default.
- W4386776723 cites W2060021945 @default.
- W4386776723 cites W2066155328 @default.
- W4386776723 cites W2068189689 @default.
- W4386776723 cites W2068840504 @default.
- W4386776723 cites W2072069770 @default.
- W4386776723 cites W2086731756 @default.
- W4386776723 cites W2087489585 @default.
- W4386776723 cites W2091209638 @default.
- W4386776723 cites W2100434903 @default.
- W4386776723 cites W2102085111 @default.
- W4386776723 cites W2102948081 @default.
- W4386776723 cites W2106762395 @default.
- W4386776723 cites W2128668604 @default.
- W4386776723 cites W2131308752 @default.
- W4386776723 cites W2153420770 @default.
- W4386776723 cites W2153584561 @default.
- W4386776723 cites W2158569602 @default.
- W4386776723 cites W2170584001 @default.
- W4386776723 cites W2170913114 @default.
- W4386776723 cites W221497585 @default.
- W4386776723 cites W2265836483 @default.
- W4386776723 cites W2320589001 @default.
- W4386776723 cites W2324855605 @default.
- W4386776723 cites W2462211283 @default.
- W4386776723 cites W2586938342 @default.
- W4386776723 cites W2607116388 @default.
- W4386776723 cites W2610726328 @default.
- W4386776723 cites W2730966137 @default.
- W4386776723 cites W2736333086 @default.
- W4386776723 cites W2747423355 @default.
- W4386776723 cites W2884677567 @default.
- W4386776723 cites W2886403656 @default.
- W4386776723 cites W2891407681 @default.
- W4386776723 cites W2915052806 @default.
- W4386776723 cites W2951903084 @default.
- W4386776723 cites W2958640546 @default.
- W4386776723 cites W2964178879 @default.
- W4386776723 cites W2974141104 @default.
- W4386776723 cites W2978484453 @default.
- W4386776723 cites W2988303912 @default.
- W4386776723 cites W2995742054 @default.
- W4386776723 cites W3006412925 @default.
- W4386776723 cites W3011880076 @default.
- W4386776723 cites W3025907794 @default.
- W4386776723 cites W3034342397 @default.
- W4386776723 cites W3041686725 @default.
- W4386776723 cites W3043817571 @default.
- W4386776723 cites W3047693299 @default.
- W4386776723 cites W3082001351 @default.
- W4386776723 cites W3096003495 @default.
- W4386776723 cites W3110773730 @default.
- W4386776723 cites W3117971832 @default.
- W4386776723 cites W3134567968 @default.
- W4386776723 cites W3173620454 @default.
- W4386776723 cites W3212406844 @default.
- W4386776723 cites W4237239211 @default.
- W4386776723 cites W4280602151 @default.
- W4386776723 cites W4283768652 @default.
- W4386776723 cites W4297832311 @default.
- W4386776723 cites W4323353251 @default.
- W4386776723 cites W4380372794 @default.
- W4386776723 doi "https://doi.org/10.1016/j.heliyon.2023.e19893" @default.
- W4386776723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37810832" @default.
- W4386776723 hasPublicationYear "2023" @default.
- W4386776723 type Work @default.
- W4386776723 citedByCount "0" @default.
- W4386776723 crossrefType "journal-article" @default.
- W4386776723 hasAuthorship W4386776723A5006780462 @default.
- W4386776723 hasAuthorship W4386776723A5019815322 @default.
- W4386776723 hasAuthorship W4386776723A5039801518 @default.
- W4386776723 hasAuthorship W4386776723A5051131961 @default.